Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04645862 · ClinicalTrials.gov registry record
Prospective 4D CTA of BAV Competence
A clinical trial of Bicuspid, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- 60
- Enrollment target
- 1
- Study location
NCT04645862 is a study of Bicuspid that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 60 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04645862, a study of Bicuspid, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The study involves annual 4D CTA imaging of the bicuspid aortic valve for a period of 5 years. CTA is often standard of care for BAV patients, but patients in this study will receive a higher radiation dose with a 4D imaging protocol. There may also be patients enrolled in the study who have a 4D CTA for research purposes when a routine CTA is not required for clinical care.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST CT scans
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2020-12-01 |
| Est. Completion | 2027-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04645862
The ClinicalTrials.gov registry entry for NCT04645862 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bicuspid appearing as the primary indexed condition, and to 1 intervention - of which CT scans is the first listed.
NCT04645862 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04645862 about?
NCT04645862 is a clinical study titled "Prospective 4D CTA of BAV Competence". The study involves annual 4D CTA imaging of the bicuspid aortic valve for a period of 5 years. CTA is often standard of care for BAV patients, but patients in this study will receive a higher radiation dose with a 4D imaging protocol. There may also be patients enrolled in the study who have a 4D CT...
What is the current status of trial NCT04645862?
This trial is currently recruiting. The enrollment target is 60 participants. The study started on 2020-12-01. Estimated completion is 2027-12-31.
What conditions does trial NCT04645862 study?
This clinical trial studies the following conditions: Bicuspid.
What interventions are being tested in trial NCT04645862?
The interventions under investigation include: CT scans (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04645862?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04645862 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.